Revmatologicka a interni ambulance
About Revmatologicka a interni ambulance
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
1
Hoffmann-La Roche
1
R-Pharm International, LLC
1
Sandoz
1
Clinical Trials at Revmatologicka a interni ambulance
During the past decade, Revmatologicka a interni ambulance conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients
2014-02-25
2023-01-19
Completed
739
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
2016-03-31
2017-09-26
Completed
353
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Revmatologicka a interni ambulance"
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "OCT Clinical Trials" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Revmatologicka a interni ambulance
According to Clinical.Site data, the most researched conditions in "Revmatologicka a interni ambulance" are
"Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Revmatologicka a interni ambulance" in a lesser frequency.
Clinical Trials Intervention Types at Revmatologicka a interni ambulance
Most popular intervention types in "Revmatologicka a interni ambulance" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab - GP2017" (1 trials), "Adalimumab - US licensed Humira" (1 trials), "Adalimumab 40mg q2w" (1 trials), "Etanercept" (1 trials) and "Filgotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Revmatologicka a interni ambulance
The vast majority of trials in "Revmatologicka a interni ambulance" are
4 trials for "All" genders.
Clinical Trials Status at Revmatologicka a interni ambulance
Currently, there are NaN active trials in "Revmatologicka a interni ambulance".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Revmatologicka a interni ambulance,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Revmatologicka a interni ambulance, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".